Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
Press Releases
Acurx Pharmaceuticals, Inc.  
April 17, 2025

Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors

STATEN ISLAND, N.Y., April 17, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for

avatar profile Olean Times Herald

Olean Times Herald


Local & Social